Stockscreener 앱 받기
6.30
90.91%
3.00
시간 외 거래:
6.19
-0.11
-1.75%
전일 마감가:
$3.30
열려 있는:
$4.09
하루 거래량:
47.26M
Relative Volume:
17.95
시가총액:
$154.63M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+104.55%
1개월 성능:
+93.85%
6개월 성능:
+218.18%
1년 성능:
-40.68%
1일 변동 폭
$4.08
$7.25
1주일 범위
$2.96
$7.25
52주 변동 폭
$1.47
$11.55
Artiva Biotherapeutics Inc Stock (ARTV) Company Profile
명칭
Artiva Biotherapeutics Inc
전화
(858) 267-4467
주소
5505 MOREHOUSE DRIVE, SAN DIEGO
ARTV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ARTV
Artiva Biotherapeutics Inc
|
6.30 | 81.00M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Artiva Biotherapeutics Inc Stock (ARTV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-11 | 재개 | H.C. Wainwright | Buy |
| 2024-12-30 | 개시 | H.C. Wainwright | Buy |
| 2024-08-13 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-08-13 | 개시 | Jefferies | Buy |
| 2024-08-13 | 개시 | Needham | Buy |
| 2024-08-13 | 개시 | TD Cowen | Buy |
| 2024-08-13 | 개시 | Wedbush | Outperform |
모두보기
Artiva Biotherapeutics Inc 주식(ARTV)의 최신 뉴스
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
US Stocks Mixed; NY Manufacturing Activity Dips In December - Benzinga
Wedbush Predicts Up to ~600% Jump for These 2 ‘Strong Buy’ Stocks - Yahoo Finance
Artiva Biotherapeutics Executes RSU Exchange for Employees - TipRanks
Pre Market Movers: XCUR, VOR, MTVA Set The Path - RTTNews
How Artiva Biotherapeutics Inc. stock trades before earningsPortfolio Growth Summary & Free Risk Controlled Daily Trade Plans - Newser
Will Artiva Biotherapeutics Inc. stock outperform tech sector in 2025Trade Exit Report & Consistent Profit Trading Strategies - Newser
Risk Hedge: Can Artiva Biotherapeutics Inc. stock rebound after recent weakness2025 Institutional Moves & Daily Growth Stock Tips - moha.gov.vn
Can Artiva Biotherapeutics Inc. stock rebound after recent weaknessDividend Hike & Free Technical Confirmation Trade Alerts - BỘ NỘI VỤ
Will Artiva Biotherapeutics Inc. stock gain from lower inflationJuly 2025 Summary & Safe Capital Growth Trade Ideas - moha.gov.vn
A new trading data show Allarity Therapeutics Inc (ALLR) is showing positive returns. - Setenews
Analysts Set Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Target Price at $19.00 - Defense World
Artiva Biotherapeutics (ARTV) Stock Analysis Report | Financials & Insights - Benzinga
LNP | LancasterOnline Events3rd Cell Therapy for Autoimmune Disease Summit - LancasterOnline
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Why Artiva Biotherapeutics Inc. stock is seen as undervalued2025 Risk Factors & Reliable Momentum Entry Alerts - newser.com
Will Artiva Biotherapeutics Inc. stock beat EPS estimatesJuly 2025 Chart Watch & Fast Entry High Yield Stock Tips - newser.com
How resilient is Artiva Biotherapeutics Inc. stock in market downturnsWeekly Investment Report & Expert Curated Trade Ideas - newser.com
Is Artiva Biotherapeutics Inc. stock attractive for retirement portfoliosWeekly Market Report & Weekly Consistent Profit Watchlists - newser.com
Why Artiva Biotherapeutics Inc. stock could rally in 2025 - newser.com
Artiva Biotherapeutics Inc. stock daily chart insights2025 Historical Comparison & Expert Verified Stock Movement Alerts - newser.com
Is Artiva Biotherapeutics Inc. stock supported by strong cash flows2025 Investor Takeaways & Long-Term Growth Portfolio Plans - newser.com
ARTV: Off-the-shelf NK cell therapy for autoimmune disease advances toward pivotal RA trial with strong safety and funding - TradingView
Artiva Biotherapeutics (NASDAQ:ARTV) CEO Sells $21,547.50 in Stock - MarketBeat
Relative strength of Artiva Biotherapeutics Inc. in sector analysisSwing Trade & Free Weekly Watchlist of Top Performers - newser.com
Aslan Fred sells Artiva Biotherapeutics (ARTV) stock for $21,522 By Investing.com - Investing.com UK
Aslan Fred sells Artiva Biotherapeutics (ARTV) stock for $21,522 - Investing.com India
Artiva Biotherapeutics Reports Positive AlloNK Trial Results - MSN
Equities Analysts Offer Predictions for ARTV FY2025 Earnings - Defense World
Why Artiva Biotherapeutics Inc. stock is popular among millennialsPortfolio Update Summary & Real-Time Volume Analysis - newser.com
How to escape a deep drawdown in Artiva Biotherapeutics Inc.Quarterly Profit Review & High Accuracy Swing Entry Alerts - newser.com
Can Artiva Biotherapeutics Inc. stock resist sector downturnsQuarterly Earnings Summary & Verified Swing Trading Watchlist - newser.com
What risks investors should watch in Artiva Biotherapeutics Inc. stock2025 Winners & Losers & Low Risk Entry Point Guides - newser.com
Published on: 2025-11-14 18:41:04 - newser.com
Why analysts remain bullish on Artiva Biotherapeutics Inc. stockJuly 2025 Macro Moves & Daily Growth Stock Investment Tips - newser.com
HC Wainwright Forecasts Strong Price Appreciation for Artiva Biotherapeutics (NASDAQ:ARTV) Stock - Defense World
Identifying reversal signals in Artiva Biotherapeutics Inc.2025 Bull vs Bear & Smart Money Movement Tracker - newser.com
Artiva Biotherapeutics Inc (ARTV) 재무 분석
Artiva Biotherapeutics Inc (ARTV)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.36%
1.05%
자본화:
|
볼륨(24시간):